Since inception, TB REACH projects have supported the diagnosis and treatment of more than 3 million people with TB in 56 countries globally and helped shape many global and national TB guidelines through evidence generation. Stop TB and Global Fund also work together to take learnings from TB REACH projects to help inform country decisions about larger investments to scale up successful approaches.
“TB REACH is the only global mechanism in the TB community that provides fast-track funding directly to implementing partners in country to test innovations. We have supported everything from donkeys to drones, artificial intelligence, portable X-ray and artificial intelligence, new molecular diagnostics, to the vital touch of human TB champions and we look forward to all the new ideas that will be made possible from FCDO’s generous Wave 11 contributions”, said Dr Lucica Ditiu, Executive Director, Stop TB Partnership.
While more people with TB were started on treatment in 2022 than ever before, globally we still miss more than 3 million who fall ill every year. TB multimorbidity is a growing concern with many people with TB having other comorbid conditions such as HIV, diabetes, malnourishment, and substance abuse – and many people who do not have TB suffer from other lung conditions.
The UK has long been at the forefront of the battle against TB and the £1 billion commitment to the Global Fund made in 2022 is making an important contribution to fighting the disease, including by providing treatment and care for 1.1 million people, screening 20 million people and providing 41,800 people with treatment for multidrug-resistant TB.
|